Testing effectiveness (Phase 2)Study completedNCT03087864
What this trial is testing
PDL-1 Targeting in Resectable Oesophageal Cancer
Who this might be right for
Esophageal Cancer, Stage IIEsophageal Cancer Stage III
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40